KKR Genetic Disorder L.P.
SEC insider (Form 3/4/5 filer). CIK 0001780408. 10% Owner at BridgeBio Pharma, Inc. (BBIO). 3 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2025. Located in NEW YORK, NY.
Companies KKR Genetic Disorder L.P. has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): 10% Owner
KKR Genetic Disorder L.P.
CIK: 0001780408
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBIO
BridgeBio Pharma, Inc.
10% Owner